Nkarta Inc (NAS:NKTX)
$ 2.87 -0.12 (-4.01%) Market Cap: 202.53 Mil Enterprise Value: 4.93 Mil PE Ratio: 0 PB Ratio: 0.47 GF Score: 38/100

Nkarta Inc at Raymond James Human Health Innovation Conference (Virtual) Transcript

Jun 21, 2021 / 07:20PM GMT
Release Date Price: $27.52 (+3.93%)
Dane Leone
Raymond James Financial, Inc. - Analyst

Greetings, everyone. Welcome to the next session here at the Raymond James 2021 Human Health Innovation Conference. My name is Dane. I'm one of the senior biotech analysts at Raymond James. With this session, I'm excited to have the Nkarta team with us. We're going to have a fireside chat and get into their NK cell platform, discuss some of the programs that they have, and hopefully answer any questions that you may have as we go along on this discussion.

To start off, I think we will have maybe, Paul, the CEO, give a grief background, introduce the team, and then we will get into some Q&A. Paul, welcome. Thank you so much for joining us.

Paul Hastings
Nkarta, Inc. - Chief Executive Officer

Dane, thank you for having us. And the beauty of Zoom is that you have the entire management team here with us today. So rather than introduce everybody, I will let you know that James Trager, our CSO, is on; Kanya Rajangam, our Chief Medical Officer, is on; Nadir Mahmood, our Chief Financial and Business

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot